Total Holdings
269
Portfolio diversification across 269 positions
IBBQ
(NASDAQ)Invesco Nasdaq Biotechnology ETF
$29.74-- (--)
Loading... - Market loading
IBBQ ETF Holdings: Invesco Nasdaq Biotechnology ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$73.26M
Total fund assets
Expense Ratio
0.19%
Annual management fee
Fund Issuer
Invesco
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 49 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Gilead Sciences, Inc. | Stock | 9.93% |
| 2 |  | Amgen Inc. | Stock | 8.90% |
| 3 |  | Vertex Pharmaceuticals Incorporated | Stock | 8.85% |
| 4 |  | Regeneron Pharmaceuticals, Inc. | Stock | 6.09% |
| 5 |  | AstraZeneca PLC | Stock | 4.11% |
| 6 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.99% |
| 7 |  | Insmed Incorporated | Stock | 2.77% |
| 8 |  | Biogen Inc. | Stock | 2.09% |
| 9 |  | argenx SE | Stock | 1.84% |
| 10 |  | Illumina, Inc | Stock | 1.67% |
| 11 |  | United Therapeutics Corporation | Stock | 1.61% |
| 12 |  | Incyte Corporation | Stock | 1.55% |
| 13 |  | Royalty Pharma plc | Stock | 1.45% |
| 14 |  | Revolution Medicines, Inc. | Stock | 1.43% |
| 15 |  | Medpace Holdings, Inc | Stock | 1.27% |
| 16 |  | Viatris Inc. | Stock | 1.27% |
| 17 |  | Moderna, Inc. | Stock | 1.23% |
| 18 |  | Roivant Sciences Ltd. | Stock | 1.13% |
| 19 |  | Guardant Health, Inc | Stock | 1.08% |
| 20 |  | Neurocrine Biosciences, Inc. | Stock | 1.06% |
| 21 |  | BridgeBio Pharma, Inc | Stock | 1.06% |
| 22 |  | Ionis Pharmaceuticals, Inc. | Stock | 1.04% |
| 23 |  | Summit Therapeutics PLC | Stock | 1.03% |
| 24 |  | Ascendis Pharma A/S | Stock | 1.03% |
| 25 |  | Sanofi | Stock | 0.96% |
| 26 |  | Madrigal Pharmaceuticals, Inc | Stock | 0.94% |
| 27 |  | Tempus AI, Inc. Class A Common Stock | Stock | 0.89% |
| 28 |  | Exelixis, Inc. | Stock | 0.87% |
| 29 |  | BioMarin Pharmaceutical Inc | Stock | 0.86% |
| 30 |  | Avidity Biosciences Inc | Stock | 0.81% |
| 31 |  | Jazz Pharmaceuticals plc | Stock | 0.75% |
| 32 | B BGNE | BeiGene, Ltd | Stock | 0.75% |
| 33 |  | BioNTech SE | Stock | 0.73% |
| 34 |  | Arrowhead Pharmaceuticals, Inc | Stock | 0.71% |
| 35 |  | Axsome Therapeutics, Inc | Stock | 0.64% |
| 36 |  | Halozyme Therapeutics, Inc | Stock | 0.64% |
| 37 |  | Caris Life Sciences, Inc. Common Stock | Stock | 0.59% |
| 38 |  | Cytokinetics, Incorporated | Stock | 0.59% |
| 39 |  | Krystal Biotech, Inc | Stock | 0.54% |
| 40 | P PINK:AAVXF | ABIVAX Société Anonyme | Stock | 0.52% |
| 41 |  | Nuvalent Inc | Stock | 0.52% |
| 42 |  | Praxis Precision Medicines, Inc | Stock | 0.50% |
| 43 |  | Rhythm Pharmaceuticals, Inc | Stock | 0.49% |
| 44 |  | PTC Therapeutics, Inc | Stock | 0.46% |
| 45 |  | Vaxcyte, Inc | Stock | 0.44% |
| 46 |  | CRISPR Therapeutics AG | Stock | 0.41% |
| 47 |  | Kymera Therapeutics, Inc | Stock | 0.39% |
| 48 |  | Protagonist Therapeutics Inc | Stock | 0.38% |
| 49 |  | Alkermes plc | Stock | 0.35% |